EE Impact

MSD

USA · Pharma & Healthcare

LeaveRussia detail: Scaling Back

Scaling back

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.

Status last verified 03/08/2026Source checked 15/04/2024Company website ↗LeaveRussia profile ↗

Business in Russia

MSD stops deliveries of chickenpox and measles medicines to Russia. The American pharmaceutical company MSD has stopped deliveries and production in Russia of Isentress based on raltegravir for patients with HIV. Roszdravnadzor confirmed that the Russian subsidiary of the American company MSD Pharmaceuticals notified the service of its plans.

Decision trail

Decision date 14/08/2023 · Reference ↗

Merck to continue supplying essential medicines and vaccines in Russia and will donate any profit from Russia to humanitarian causes, the company will not make further investments in Russia, This includes stopping all promotional activities, capital investments and business development initiatives, Additionally, screening and enrollment in ongoing clinical trials, and planning for new studies in Russia have been suspended,

Local stats (LeaveRussia)

Assets(RF), mln.USD
166
Capital(RF), mln.USD
108
Glob.Revenue, mln.USD
59283
Revenue(RF), mln.USD
201
Staff(RF), 2021
995

Status history since 2022

  1. 03/08/2026 scaling back · Imported from KSE LeaveRussia

Possible sanctions matches

Name-based matches against EU/US/UK lists — verify identity before drawing conclusions.

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.